Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

SEC Filings

SEC Filings

Filing date Description Form View

Annual report which provides a comprehensive overview of the company for the past year

10-K EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Annual report which provides a comprehensive overview of the company for the past year

10-K EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Amendment to a previously filed 10-K

10-K/A View HTML

Amendment to a previously filed 10-K

10-K/A View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Copyright Morningstar